Kangwei Century: Subsidiary obtains its 8th Class III certificate for gastrointestinal pathogens.

Kangwei Century announced that the Clostridioides difficile tpi and toxin A and toxin B gene detection kit independently developed by the company's wholly owned subsidiary Jiangsu Jianwei Diagnostic Technology Co., Ltd. has recently obtained a Class III Medical Device Registration Certificate issued by the National Medical Products Administration. The approval and effective date of the registration certificate is September 14, 2026. This is the company's 8th Class III medical device registration certificate obtained for gastrointestinal pathogen detection.